355 related articles for article (PubMed ID: 33338041)
21. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A
Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Cardoso JMO; Brito RCF; Mathias FAS; Reis LES; Vieira JFP; Ostolin TLVDP; Andrade HM; Ramos GS; Frézard F; Aguiar-Soares RDO; Roatt BM; Reis AB
Mol Immunol; 2022 Jan; 141():70-78. PubMed ID: 34814056
[TBL] [Abstract][Full Text] [Related]
23. Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.
Ribeiro RR; Moura EP; Pimentel VM; Sampaio WM; Silva SM; Schettini DA; Alves CF; Melo FA; Tafuri WL; Demicheli C; Melo MN; Frézard F; Michalick MS
Antimicrob Agents Chemother; 2008 Jul; 52(7):2564-72. PubMed ID: 18458133
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin.
Pennisi MG; De Majo M; Masucci M; Britti D; Vitale F; Del Maso R
Vet Rec; 2005 Mar; 156(11):346-9. PubMed ID: 15789648
[TBL] [Abstract][Full Text] [Related]
25. Tongue nodules in canine leishmaniosis--a case report.
Viegas C; Requicha J; Albuquerque C; Sargo T; Machado J; Dias I; Pires MA; Campino L; Cardoso L
Parasit Vectors; 2012 Jun; 5():120. PubMed ID: 22704596
[TBL] [Abstract][Full Text] [Related]
26. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
[TBL] [Abstract][Full Text] [Related]
27. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
28. Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis.
da Silva SM; Amorim IF; Ribeiro RR; Azevedo EG; Demicheli C; Melo MN; Tafuri WL; Gontijo NF; Michalick MS; Frézard F
Antimicrob Agents Chemother; 2012 Jun; 56(6):2858-67. PubMed ID: 22411610
[TBL] [Abstract][Full Text] [Related]
29. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy.
Alvar J; Molina R; San Andrés M; Tesouro M; Nieto J; Vitutia M; González F; San Andrés MD; Boggio J; Rodriguez F
Ann Trop Med Parasitol; 1994 Aug; 88(4):371-8. PubMed ID: 7979624
[TBL] [Abstract][Full Text] [Related]
30. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases).
Denerolle P; Bourdoiseau G
J Vet Intern Med; 1999; 13(5):413-5. PubMed ID: 10499722
[TBL] [Abstract][Full Text] [Related]
31. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
Gramiccia M; Gradoni L; Orsini S
Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703
[TBL] [Abstract][Full Text] [Related]
32. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
[TBL] [Abstract][Full Text] [Related]
33. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M
Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789
[TBL] [Abstract][Full Text] [Related]
34. Current status on prevention and treatment of canine leishmaniasis.
Reguera RM; Morán M; Pérez-Pertejo Y; García-Estrada C; Balaña-Fouce R
Vet Parasitol; 2016 Aug; 227():98-114. PubMed ID: 27523945
[TBL] [Abstract][Full Text] [Related]
35. Value of Western blotting in the clinical follow-up of canine leishmaniasis.
Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM
J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Navarro-Moll MC; Morillas-Márquez F; Martín-Sánchez J
Vet Res Commun; 2018 Jun; 42(2):121-130. PubMed ID: 29453596
[TBL] [Abstract][Full Text] [Related]
37. First Report of an Urban Case of Canine Visceral Leishmaniasis in the Municipality of Cali, Colombia.
Arbeláez N; Moreno J; Murillo J; Montoya A; Robledo SM; Vélez A; Vélez ID
Am J Trop Med Hyg; 2020 Feb; 102(2):289-293. PubMed ID: 31802736
[TBL] [Abstract][Full Text] [Related]
38. Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis.
Ayres EDCBS; Dias ÁFLR; Monteiro BRG; Pazzini SS; Barbosa MEC; Silva EBD; Macedo LFDC; Sousa VRF; Dutra V; Nakazato L; Almeida ADBPF
Rev Bras Parasitol Vet; 2022; 31(3):e007222. PubMed ID: 35920471
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
[TBL] [Abstract][Full Text] [Related]
40. Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound.
Segarra S; Miró G; Montoya A; Pardo-Marín L; Teichenné J; Ferrer L; Cerón JJ
Parasit Vectors; 2018 Feb; 11(1):103. PubMed ID: 29467015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
